THE DEVASTATING effects of glomerular nephritis and the considerable disability induced by this disease are well known. The fact that nephritis has a predilection for children and young adults serves as an additional stimulus to the search for a means of controlling the disease. To date, therapy is limited to procedures which ameliorate the metabolic abnormalities secondary to renal failure or attempts to reduce the incidence of intercurrent infections. The dramatic effect which pituitary adrenocorticotropic hormone (ACTH) and cortisone1 exert on the course of a wide variety of systemic diseases of unknown origin, especially those in which an antigen-antibody type of reaction is believed to play an important etiologic role, stimulated us to investigate the possible beneficial effect of these hormones in patients with glomerular nephritis. Furthermore, earlier studies 2 indicating an apparent competitive inhibition of cortisone on excessive sodium retention induced by desoxycorticosterone naturally suggested an investigation of
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 56
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.